[go: up one dir, main page]

TNSN91067A1 - Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues. - Google Patents

Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues.

Info

Publication number
TNSN91067A1
TNSN91067A1 TNTNSN91067A TNSN91067A TNSN91067A1 TN SN91067 A1 TNSN91067 A1 TN SN91067A1 TN TNSN91067 A TNTNSN91067 A TN TNSN91067A TN SN91067 A TNSN91067 A TN SN91067A TN SN91067 A1 TNSN91067 A1 TN SN91067A1
Authority
TN
Tunisia
Prior art keywords
compositions
preparation
particles
sustained release
active ingredient
Prior art date
Application number
TNTNSN91067A
Other languages
English (en)
Inventor
Marc Ruiz Jean
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of TNSN91067A1 publication Critical patent/TNSN91067A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Glanulating (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'INVENTION CONCERNE UN PROCEDE DE PREPARATION DE PARTICULES CONCUES POUR LIBERER UNE QUANTITE EFFICACE DE PRINCIPE ACTIF SUR UNE PERIODE DE TEMPS DETERMINEE, LESDITES PARTICULES COMPRENANT UN OU PLUSIEURS PRINCIPES ACTIFS DANS UN MELANGE AVEC UN POLYMERE OU COPOLYMERE BIORESORBABLE ET/OU BIODEGRADABLE, ET LES PARTICULES AINSI OBTENUES AYANT UNE FORME SUBSTANTIELLEMENT SPHEROIDALE ET SUBSTANTIELLEMENT DEPOURVUES DE PRINCIPE ACTIF SUR LA SURFACE EXTERNE.
TNTNSN91067A 1990-08-01 1991-07-30 Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues. TNSN91067A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909016885A GB9016885D0 (en) 1990-08-01 1990-08-01 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
TNSN91067A1 true TNSN91067A1 (fr) 1992-10-25

Family

ID=10679993

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN91067A TNSN91067A1 (fr) 1990-08-01 1991-07-30 Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues.

Country Status (30)

Country Link
US (1) US5213812A (fr)
JP (1) JP2818704B2 (fr)
KR (1) KR920003962A (fr)
AT (1) AT396425B (fr)
AU (2) AU649696B2 (fr)
BE (1) BE1004772A3 (fr)
CA (1) CA2048270C (fr)
CH (1) CH682715A5 (fr)
DE (1) DE4125542A1 (fr)
DK (1) DK175756B1 (fr)
ES (1) ES2046083B1 (fr)
FI (1) FI104149B1 (fr)
FR (1) FR2665360B1 (fr)
GB (1) GB9016885D0 (fr)
GR (1) GR1001512B (fr)
HK (1) HK33294A (fr)
IE (1) IE65124B1 (fr)
IN (1) IN178446B (fr)
IT (1) IT1251788B (fr)
LU (1) LU87982A1 (fr)
MA (1) MA22245A1 (fr)
MY (1) MY107500A (fr)
NL (1) NL194637C (fr)
NO (1) NO300158B1 (fr)
NZ (1) NZ238981A (fr)
OA (1) OA09387A (fr)
PT (1) PT98497B (fr)
SE (1) SE505734C2 (fr)
TN (1) TNSN91067A1 (fr)
ZA (1) ZA915565B (fr)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
US5569467A (en) * 1993-05-15 1996-10-29 Societe De Conseils De Recherches Et D'applications (S.C.R.A.S.) Process for the preparation of microballs and microballs thus obtained
WO1995022963A1 (fr) * 1994-02-28 1995-08-31 Medinova Medical Consulting Gmbh Systeme de ciblage d'un medicament, procede de preparation et utilisation de ce medicament
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
DE19604744A1 (de) 1996-02-09 1997-08-14 Henkel Kgaa Technische Di-/Triglyceridgemische
DE19617137C1 (de) * 1996-04-29 1997-02-27 Henkel Kgaa Verwendung von Copolymerestern für die Herstellung von Mikrosphären
WO1998015263A2 (fr) * 1996-10-09 1998-04-16 Takeda Chemical Industries, Ltd. Procede de production d'une microparticule
TW577759B (en) * 1997-04-18 2004-03-01 Ipsen Pharma Biotech Sustained release compositions in the form of microcapsules or implants and the process for their preparation
EP1079967A4 (fr) 1998-04-13 2003-07-23 Luminex Corp Marquage liquide a l'aide de microparticules fluorescentes
HK1041645B (zh) * 1998-12-16 2005-07-29 Aventisub Ii Inc. 生物可降解聚合物包封的5-羟色胺受体拮抗剂及其制备方法
AU5644400A (en) * 1999-09-24 2001-03-29 Rohm And Haas Company Pellet compositions
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
ATE430558T1 (de) 2000-10-27 2009-05-15 Baxter Healthcare Sa Herstellung von mikrokügelchen
US20030064033A1 (en) * 2001-08-16 2003-04-03 Brown Larry R. Propellant-based microparticle formulations
US20080026068A1 (en) * 2001-08-16 2008-01-31 Baxter Healthcare S.A. Pulmonary delivery of spherical insulin microparticles
US20040166077A1 (en) * 2002-12-04 2004-08-26 L'oreal Process for treating keratin materials with aromatic active principles
FR2848113B1 (fr) * 2002-12-04 2005-02-25 Oreal Stabilisation de principes actifs aromatiques par des polymeres aromatiques
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
US20050142201A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for fabrication, uses and compositions of small spherical particles of hGH prepared by controlled phase separation
CA2532874A1 (fr) * 2003-07-22 2005-02-03 Baxter International Inc. Petites particules spheriques de molecules organiques de faible poids moleculaire et procedes de preparation et d'utilisation correspondants
US20060135277A1 (en) * 2003-09-10 2006-06-22 Marnocha Bendict F Golf club and practice arrangement
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
ATE409025T1 (de) * 2004-05-12 2008-10-15 Baxter Int Nukleinsäure-mikrokügelchen, ihre herstellung und abgabe
EP1753404A1 (fr) * 2004-05-12 2007-02-21 Baxter International Inc. Microsphères contenant des protéines et présentant un potentiel d"injectabilité à d"importants degrés de concentration de l"agent concerné
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
AU2005244851B2 (en) * 2004-05-12 2010-08-26 Baxter Healthcare S.A. Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
AU2005271781A1 (en) * 2004-07-13 2006-02-16 Altairnano, Inc. Ceramic structures for prevention of drug diversion
EP1773264A1 (fr) * 2004-07-13 2007-04-18 Altairnano, Inc Structures de ceramique pour la liberation controlee de medicaments
EP1812920A1 (fr) * 2004-10-29 2007-08-01 Adhesives Research, Inc. Systeme de marquage microscopique pour une identification securisee
EP1885335A1 (fr) * 2005-04-27 2008-02-13 BAXTER INTERNATIONAL INC. (a Delaware corporation) Microparticules a surface modifiee et procedes de formation et d'utilisation associes
AU2006283170A1 (en) * 2005-08-23 2007-03-01 Altairnano, Inc. Highly photocatalytic phosphorus-doped anatase-TiO2 composition and related manufacturing methods
US20080020175A1 (en) * 2006-03-02 2008-01-24 Fred Ratel Nanostructured Indium-Doped Iron Oxide
WO2007103829A1 (fr) * 2006-03-02 2007-09-13 Altairnano, Inc. Procédé de production de revêtements d'oxydes métalliques
WO2007103812A1 (fr) * 2006-03-02 2007-09-13 Altairnano, Inc. Procédé de production à basse température de revêtements d'oxyde de fer nanostructurés
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
CN105168146A (zh) 2006-08-04 2015-12-23 巴克斯特国际公司 预防和/或逆转新发作自身免疫糖尿病的基于微球的组合物
MX2009003661A (es) * 2006-10-06 2009-04-22 Baxter Int Microcapsulas que contienen microparticulas modificadas en la superficie y metodos para formar y utilizar las mismas.
CA2702340C (fr) 2006-10-12 2014-12-16 The University Of Queensland Compositions et procedes destines a moduler des reponses immunes
US20090169628A1 (en) 2006-10-17 2009-07-02 Armark Authentication Technologies, Llc Article and method for focused delivery of therapeutic and/or diagnostic materials
US20080254258A1 (en) * 2007-04-12 2008-10-16 Altairnano, Inc. Teflon® replacements and related production methods
US8808747B2 (en) * 2007-04-17 2014-08-19 Baxter International Inc. Nucleic acid microparticles for pulmonary delivery
US9782300B2 (en) 2008-02-01 2017-10-10 Kci Licensing, Inc. Fiber-microsphere bioresorbable composite scaffold for wound healing
WO2009129544A1 (fr) 2008-04-18 2009-10-22 Baxter International Inc. Composition à base de microsphères pour prévenir et/ou inverser une nouvelle apparition de diabète auto-immun
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
WO2010037021A2 (fr) * 2008-09-29 2010-04-01 Armark Authentication Technologies, Llc Filière et procédé de filage d’une fibre
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
WO2010132763A1 (fr) * 2009-05-15 2010-11-18 Armark Authentication Technologies, Llc Fibre présentant une composition non uniforme et procédé de fabrication
WO2010138194A2 (fr) 2009-05-27 2010-12-02 Selecta Biosciences, Inc. Composés agents immunomodulateurs-polymères
EP2480596A1 (fr) * 2009-09-25 2012-08-01 Armark Authentication Technologies, LLC Echafaudage de fibres tissulaires et procédé de réalisation
US20110293700A1 (en) 2010-05-26 2011-12-01 Selecta Biosciences, Inc. Nanocarrier compositions with uncoupled adjuvant
EP2399931A1 (fr) * 2010-06-22 2011-12-28 Ipsen Pharma S.A.S. Nouveaux composés octapeptidiques et leur utilisation thérapeutique
BR112013010926A2 (pt) 2010-11-01 2016-08-23 Univ Technology Sidney agentes imunomoduladores e seus usos
WO2013019648A1 (fr) 2011-07-29 2013-02-07 Selecta Biosciences, Inc. Contrôle des réponses d'anticorps envers des nanosupports synthétiques
WO2015179918A1 (fr) 2014-05-27 2015-12-03 The University Of Queensland Modulation de stress cellulaire
FR3067226B1 (fr) * 2017-06-13 2021-10-08 Rossignol Lange Element de chaussure de ski

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567650A (en) * 1969-02-14 1971-03-02 Ncr Co Method of making microscopic capsules
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
IN167096B (fr) * 1985-04-04 1990-09-01 Akzo Nv
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
EP0366058A3 (fr) * 1988-10-27 1991-03-20 Abbott Laboratories Dispositif de délivrance à libération contrôlée, procédé de préparation du dispositif et méthode d'utilisation du dispositif

Also Published As

Publication number Publication date
AU666808B2 (en) 1996-02-22
FI104149B (fi) 1999-11-30
ZA915565B (en) 1992-04-29
SE9102249L (sv) 1992-02-02
DE4125542A1 (de) 1992-02-06
DK175756B1 (da) 2005-02-14
DK141891D0 (da) 1991-07-31
CA2048270C (fr) 1997-02-25
MA22245A1 (fr) 1992-04-01
NL194637B (nl) 2002-06-03
NO912986L (no) 1992-02-03
JP2818704B2 (ja) 1998-10-30
ES2046083B1 (es) 1994-08-01
PT98497A (pt) 1992-06-30
MY107500A (en) 1995-12-30
NL9101306A (nl) 1992-03-02
FR2665360B1 (fr) 1995-02-10
NL194637C (nl) 2002-10-04
AU5939394A (en) 1994-06-02
CA2048270A1 (fr) 1992-02-02
IN178446B (fr) 1997-05-03
US5213812A (en) 1993-05-25
JPH05178740A (ja) 1993-07-20
FR2665360A1 (fr) 1992-02-07
AU8146691A (en) 1992-02-06
SE9102249D0 (sv) 1991-07-26
IE65124B1 (en) 1995-10-04
ATA152591A (de) 1993-01-15
KR920003962A (ko) 1992-03-27
GR1001512B (el) 1994-02-28
FI104149B1 (fi) 1999-11-30
HK33294A (en) 1994-04-22
AT396425B (de) 1993-09-27
CH682715A5 (fr) 1993-11-15
IT1251788B (it) 1995-05-26
ITMI911953A1 (it) 1993-01-15
NO300158B1 (no) 1997-04-21
SE505734C2 (sv) 1997-10-06
ES2046083A1 (es) 1994-01-16
FI913646L (fi) 1992-02-02
ITMI911953A0 (it) 1991-07-15
DK141891A (da) 1992-02-02
IE912700A1 (en) 1992-02-12
BE1004772A3 (fr) 1993-01-26
GB9016885D0 (en) 1990-09-12
FI913646A0 (fi) 1991-07-31
PT98497B (pt) 1997-10-31
NO912986D0 (no) 1991-07-31
NZ238981A (en) 1992-11-25
GR910100330A (en) 1992-08-31
LU87982A1 (fr) 1992-04-15
OA09387A (fr) 1992-09-15
AU649696B2 (en) 1994-06-02

Similar Documents

Publication Publication Date Title
TNSN91067A1 (fr) Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues.
HUT56236A (en) Biocidal and agrochemical suspension compositions
ES2166919T3 (es) Preparacion de un dispositivo dosificador.
MX9504252A (es) Composicion farmaceutica solida que comprende un excipiente capaz de ligar agua.
ATE213405T1 (de) Ophthalmische zusammensetzungen mit verlängerte freisetzung enthaltend im wasser lösliche arzneistoffe
CA2265766A1 (fr) Pastilles se desintegrant rapidement
CU22361A1 (es) Composiciones biocidas y agroquimicas
BR9804295A (pt) Sistema de liberação micelar misto e método de preparação.
CA2281473A1 (fr) Forme galenique presentant des proprietes de dispersion rapide, ses procedes d'utilisation et son procede de preparation
KR960021061A (ko) 경구 투여용 약제학적 조성물
MX9802849A (es) Una composicion antibacteriana para administracion oral.
DK0696168T3 (da) Koncentrerede faste sammensætninger med aktive stoffer til landbrug
CA2132544A1 (fr) Antagonistes d'angiotensine ii utiles contre les troubles lies a une vitesse alteree de l'influx nerveux, particulierement dans le cas de la neuropathie diabetique
CA2178163A1 (fr) Compositions granulaires solubles dans l'eau comprenant un herbicide a base d'imidazolinone et une base
GB9709853D0 (en) Molluscicides
RU95118013A (ru) Препарат сульфадин для профилактики и лечения гинекологических заболеваний у коров
JPS57118509A (en) Novel preparation of high absorbability
Canta et al. Research on Rotary Forging of Conical Gears
JPS642537A (en) Attractant for fishes
Sina et al. An historical perspective[Bovine Corneal Opacity and Permeability]
Zabowski et al. Physico-chemical composition of liquid manure.
Mlinarsik et al. Development of Light-Stabilized Broad Foils for Agriculture at the TISZA Chemical Combine
Safaya et al. A comparative evaluation of spermicidal activities of iron salts
JPS6416A (en) Remedy for arthritis
RU2002110950A (ru) Твердосмазочная композиция и способ формирования покрытия на трущихся поверхностях с её использованием